Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

US Regulators Target MicroStrategy and Crypto Treasury Sector

Andreas Sommer by Andreas Sommer
September 28, 2025
in Stocks
0
Strategy Stock
0
SHARES
103
VIEWS
Share on FacebookShare on Twitter

The US Securities and Exchange Commission (SEC), in coordination with the Financial Industry Regulatory Authority (FINRA), has initiated a sweeping investigation into potential market manipulation, placing MicroStrategy and the broader corporate crypto treasury sector under intense scrutiny. The probe encompasses more than 200 companies that have adopted cryptocurrency treasury strategies, raising fundamental questions about the sustainability of so-called Bitcoin proxy stocks.

At the heart of the inquiry are suspicious trading patterns observed prior to public announcements of Bitcoin purchases. Regulators are examining whether unusual price movements immediately before these disclosures indicate possible violations of rules concerning the selective sharing of insider information. This timing has triggered significant concern among financial watchdogs.

A Pioneering Business Model Under Pressure

MicroStrategy, a trailblazer in the corporate Bitcoin treasury space since August 2020, now holds a staggering 638,985 Bitcoins. Its strategy of raising capital through equity offerings to fund Bitcoin acquisitions has been widely replicated, effectively creating a new asset class of Bitcoin-linked equities. However, this very model is now facing its most serious challenge.

The company’s aggressive capital-raising efforts could be jeopardized by the investigation. MicroStrategy currently has various equity programs in place, representing an available volume of approximately $46.6 billion for future share sales. The entire business premise is contingent on continuous access to capital markets, which regulatory action could severely disrupt.

Valuation Pressures and Sector-Wide Vulnerability

Compounding the regulatory uncertainty are underlying valuation issues. According to research from K33, about 25% of companies with Bitcoin treasuries are already trading below the value of their digital asset holdings. This discount makes it increasingly difficult to raise fresh capital for additional purchases.

Should investors sell immediately? Or is it worth buying Strategy?

MicroStrategy’s stock performance has recently decoupled from Bitcoin’s price trajectory, exhibiting even greater volatility. After reaching a 52-week high of $543 in November 2024, its shares have retreated to around $335. This heightened fluctuation underscores the unique risks associated with the Bitcoin treasury model.

The implications of the regulatory crackdown extend far beyond a single company. Should authorities uncover securities law violations, the operational framework for the entire sector of over 200 firms could be fundamentally reshaped. This scrutiny persists despite the Trump administration’s generally supportive stance toward cryptocurrencies, which includes plans for a strategic Bitcoin reserve and approvals for 401(k) plans to include digital assets.

Ambitious Goals Amidst Mounting Challenges

Despite the headwinds, MicroStrategy’s leadership has outlined ambitious financial targets. Company management projects profits of $20 billion and an operating income of $34 billion for 2025, predicated on Bitcoin reaching a price of $150,000 by the end of that year.

All eyes will be on the next quarterly results, scheduled for October 28, for management’s assessment of the regulatory landscape. Market expectations, reflected in the Zacks consensus estimate, forecast a loss of $15.73 per share for 2025—a stark indicator of the inherent volatility embedded within the Bitcoin treasury strategy. The upcoming report will be a critical test of investor confidence in the face of escalating regulatory pressure.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from February 7 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
QuantumScape Stock

QuantumScape's Solid-State Battery Breakthrough Faces Market Test

Rocket Lab USA Stock

Rocket Lab Leadership Triggers Investor Alarm with Major Stock Sales

Super Micro Computer Stock

Super Micro's AI Server Business Faces Critical Market Test

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com